MedPath

Detection of Right Ventricular Dysfunction by Portal Vein Doppler After Cardiac Surgery

Not Applicable
Completed
Conditions
Postoperative Complications
Heart Failure
Heart Diseases
Heart Valve Diseases
Interventions
Other: cardiac surgery involving mitral or tricuspid valve repair procedure, with cardiopulmonary bypass
Registration Number
NCT04890860
Lead Sponsor
CMC Ambroise Paré
Brief Summary

Right ventricular (RV) failure after cardiac surgery is associated with morbidity and mortality, but is hard to diagnose with conventional echocardiographic means. RV dysfunction may be associated with hepatic congestion, which may have an effect on portal veinous flow, but this has not been extensively. The investigators aimed determine whether an increased pulsatility in the portal venous flow was associated with RV dysfunction, after cardiac surgery at risk of RV dysfunction: mitral and tricuspid valve procedures.

Detailed Description

In cardiac surgical patients, RV dysfunction is associated with organ hypoperfusion and venous congestion leading to increased morbidity and mortality.

Non-invasive methods used to assess RV function are 2D-echocardiographic measurement of tricuspid annular plane systolic excursion (TAPSE), RV ejection fraction (EF), RV fractional area change (FAC), 3D assessment of RV function, tissue Doppler assessment of velocities, and magnetic resonance imaging (MRI). Though MRI is the gold standard method to assess RV function, it cannot be used in the perioperative period.

In the present prospective observational study, The investigators investigated the association between the pattern of portal venous flow and RV function as assessed by echocardiography in the postoperative period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • More than 18 years old
  • Ability to provide an informed consent
  • Planned mitral and / or tricuspid valve surgery under cardiopulmonary bypass.
Exclusion Criteria
  • Insufficient echogenicity

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adults patients undergoing mitral and / or tricuspid valve surgery with cardiopulmonary bypass.cardiac surgery involving mitral or tricuspid valve repair procedure, with cardiopulmonary bypass-
Primary Outcome Measures
NameTimeMethod
Right ventricular failureFirst 24 hours post cardiac surgery

1. systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)

2. RV fractional area change below 35%

3. End-diastole diameter ratio between RV and left ventricle \> 0.6

4. Ratio between S and D wave or inverse D wave in supra-hepatic veins

Portal flow measured by DopplerFirst 24 hours post cardiac surgery

flow pulsatility is assessed with the formula = 100 x (Vmax-Vmin)/Vmax. Time frame: First 24 hours post cardiac surgery

Secondary Outcome Measures
NameTimeMethod
Echocardiographic acquisitionFirst 24 hours post cardiac surgery

Feasability of all measurements (RV failure with the portal flow with Doppler)

Concordance of pulsatile flow assessmentFirst 24 hours post cardiac surgery

Concordance of repeated measurements of the venous portal flow Time frame: First 24 hours post cardiac surgery

Concordance of RV dysfunction measurementsFirst 24 hours post cardiac surgery

Concordance of repeated measurements of :

1. systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)

2. RV fractional area change below 35%

3. End-diastole diameter ratio between RV and left ventricle \> 0.6

4. Ratio between S and D wave or inverse D wave in supra-hepatic veins

Preoperative RV dysfunction30 days before cardiac surgery

As defined

1. systolic dysfunction (TAPSE below 16 mm or S wave below 9.5 cm/s)

2. RV fractional area change below 35%

3. End-diastole diameter ratio between RV and left ventricle \> 0.6

4. Ratio between S and D wave or inverse D wave in supra-hepatic veins

Acute kidney injuryone week after surgery

defined by KDIGO criteria as creatininemia elevation above \> 26 micromol/L during the first 48 hours or +50% during the first week, oliguria with urine output less than 0.5 mL/kg/h during 6 hours.

Cholestasisone week after surgery

Conjugate bilirubin elevation above 12 mmol/L

Trial Locations

Locations (1)

CMC Ambroise Paré

🇫🇷

Neuilly-sur-Seine, France

© Copyright 2025. All Rights Reserved by MedPath